OTCPK:DMHI

Stock Analysis Report

Executive Summary

DMH International, Inc., through its subsidiaries, develops a suite of medical software products in the United States.

Snowflake

Fundamentals

Adequate balance sheet with weak fundamentals.

Risks

  • DMH International has significant price volatility in the past 3 months.
  • DMH International's last earnings update was 1032 days ago.
  • DMH International is not covered by any analysts.

Share Price & News

How has DMH International's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-99.9%

DMHI

2.5%

US Healthcare Services

-0.6%

US Market


1 Year Return

-99.8%

DMHI

10.3%

US Healthcare Services

0.6%

US Market

DMHI underperformed the Healthcare Services industry which returned 8.7% over the past year.

DMHI underperformed the Market in United States of America which returned 1.1% over the past year.


Share holder returns

DMHIIndustryMarket
7 Day-99.9%2.5%-0.6%
30 Day-99.9%-2.9%2.2%
90 Day-99.9%-4.1%1.1%
1 Year-99.8%-99.8%10.4%10.3%2.9%0.6%
3 Year-99.9%-99.9%51.9%51.6%44.6%35.2%
5 Year-100.0%-100.0%52.0%51.1%61.9%44.2%

Price Volatility Vs. Market

How volatile is DMH International's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is DMH International undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether DMH International is trading at an attractive price based on the cash flow it is expected to produce in the future. But as DMH International has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Examine DMH International's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through DMH International regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is DMH International expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

27.7%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as DMH International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has DMH International performed over the past 5 years?

0.2%

Historical Healthcare annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, DMH International has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

Financial Health

How is DMH International's financial position?


In this section we usually analyse DMH International's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. DMH International has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of DMHI’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when DMH International's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is DMH International's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate DMH International's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate DMH International's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as DMH International has not reported any payouts.

Unable to verify if DMH International's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as DMH International has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of DMH International's salary, the management and board of directors tenure and is there insider trading?

5.6yrs

Average board tenure


CEO

George England (55yo)

5.2yrs

Tenure

US$291,237

Compensation

Mr. George W. England, Jr. has been the Chief Executive Officer and President of DMH International, Inc. since July 22, 2014. Mr. England has over 26 years of experience as a healthcare entrepreneur and ex ...


CEO Compensation Analysis

Insufficient data for George to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.

No earnings data for DMH International, not possible to compare to compensation.


Board Age and Tenure

5.6yrs

Average Tenure

53yo

Average Age

The tenure for the DMH International board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Management Team

  • Rik Deitsch (51yo)

    Chairman

    • Tenure: 6.8yrs
  • George England (55yo)

    Chief Executive Officer

    • Tenure: 5.2yrs
    • Compensation: US$291.24k
  • Will McCullough

    Chief Technology Officer

    • Tenure: 0yrs

Board Members

  • Michael Flax (63yo)

    Member of Medical Advisory Board

    • Tenure: 5.5yrs
  • Rik Deitsch (51yo)

    Chairman

    • Tenure: 6.8yrs
  • Jeffrey Fernyhough

    Member of Medical Advisory Board

    • Tenure: 5.7yrs
  • Jonathan Hyde

    Member of Medical Advisory Board

    • Tenure: 4.8yrs
  • Jason Barry (47yo)

    Director

    • Tenure: 6.8yrs
    • Compensation: US$60.00k
  • George England (55yo)

    Chief Executive Officer

    • Tenure: 5.2yrs
    • Compensation: US$291.24k
  • Anthony Alberico

    Member of Medical Advisory Board

    • Tenure: 0yrs
  • Fernando Diaz

    Member of Medical Advisory Board

    • Tenure: 0yrs
  • William Smith

    Member of Medical Advisory Board

    • Tenure: 0yrs

Company Information

DMH International, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: DMH International, Inc.
  • Ticker: DMHI
  • Exchange: OTCPK
  • Founded: 2010
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$435.000
  • Shares outstanding: 435.96m
  • Website: https://www.touchmedicalsolutions.com

Number of Employees


Location

  • DMH International, Inc.
  • 12502 West Atlantic Boulevard
  • Coral Springs
  • Florida
  • 33071
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
DMHIOTCPK (Pink Sheets LLC)YesNew Common StockUSUSDJul 2012

Biography

DMH International, Inc., through its subsidiaries, develops a suite of medical software products in the United States. It is developing TouchERP, a medical enterprise resource planning solution; TouchPMS,  ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/21 00:11
End of Day Share Price2019/09/16 00:00
Earnings2016/09/30
Annual Earnings2015/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.